Portal:COVID-19/FeaturedPathways
From WikiPathways
(→SARS-CoV-2 Pathways) |
(fixed styling) |
||
Line 10: | Line 10: | ||
|width=100px|{{#pwImage:Pathway:WP4927|250px||COVID-19, thrombosis and anticoagulation}} | |width=100px|{{#pwImage:Pathway:WP4927|250px||COVID-19, thrombosis and anticoagulation}} | ||
|- | |- | ||
- | |||
- | |||
|width=100px|{{#pwImage:Pathway:WP4876|250px||Activation of NLRP3 Inflammasome by SARS-CoV-2}} | |width=100px|{{#pwImage:Pathway:WP4876|250px||Activation of NLRP3 Inflammasome by SARS-CoV-2}} | ||
Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. | Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. | ||
Line 20: | Line 18: | ||
Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis | Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis | ||
|- | |- | ||
- | |||
- | |||
|width=100px|{{#pwImage:Pathway:WP4904|250px||LDLRAD4 pathway in COVID-19}} | |width=100px|{{#pwImage:Pathway:WP4904|250px||LDLRAD4 pathway in COVID-19}} | ||
|width=100px|{{#pwImage:Pathway:WP4936|250px||Overview of perturbations to host-cell autophagy, induced by distinct proteins of SARS-CoV-2 (Homo sapiens)}} | |width=100px|{{#pwImage:Pathway:WP4936|250px||Overview of perturbations to host-cell autophagy, induced by distinct proteins of SARS-CoV-2 (Homo sapiens)}} | ||
Line 27: | Line 23: | ||
|width=100px|{{#pwImage:Pathway:WP4969|250px||RAS and Bradykinin pathways in COVID-19 (Homo sapiens)}} | |width=100px|{{#pwImage:Pathway:WP4969|250px||RAS and Bradykinin pathways in COVID-19 (Homo sapiens)}} | ||
|- | |- | ||
- | |||
- | |||
|width=100px|{{#pwImage:Pathway:WP5027|250px||nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell}} | |width=100px|{{#pwImage:Pathway:WP5027|250px||nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell}} | ||
|- | |- | ||
Line 42: | Line 36: | ||
|width=100px|{{#pwImage:Pathway:WP4912|250px||SARS coronavirus and innate immunity}} | |width=100px|{{#pwImage:Pathway:WP4912|250px||SARS coronavirus and innate immunity}} | ||
|- | |- | ||
- | |||
- | |||
|width=100px|{{#pwImage:Pathway:WP4861|250px||ER stress response in Coronavirus infection}} | |width=100px|{{#pwImage:Pathway:WP4861|250px||ER stress response in Coronavirus infection}} | ||
|width=100px|{{#pwImage:Pathway:WP4799|250px||Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein}} | |width=100px|{{#pwImage:Pathway:WP4799|250px||Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein}} | ||
Line 49: | Line 41: | ||
|width=100px|{{#pwImage:Pathway:WP4880|250px||Host-pathogen interaction of human corona viruses - Interferon induction}} | |width=100px|{{#pwImage:Pathway:WP4880|250px||Host-pathogen interaction of human corona viruses - Interferon induction}} | ||
|- | |- | ||
- | |||
- | |||
|width=100px|{{#pwImage:Pathway:WP4965|250px||Deregulation of the Renin Angiotensin system by Sars-CoV infection}} | |width=100px|{{#pwImage:Pathway:WP4965|250px||Deregulation of the Renin Angiotensin system by Sars-CoV infection}} | ||
|- | |- |
Revision as of 05:09, 6 January 2021
Contents |
SARS-CoV-2 Pathways
Image does not exist Collaborative project for curation of biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
Image does not exist SARS-CoV-2 includes a novel Orf10 that interacts with multiple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
Image does not exist |
Image does not exist Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist |
Image does not exist Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways |
Image does not exist Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Other coronaviruses: MERS, SARS-CoV, etc
Image does not exist Lipid metabolism alternations that are related to infection by the corona virus. |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
More about ACE2
Image does not exist |
Image does not exist |
Pathways from Reactome
Image does not exist |
Image does not exist |
List of featured pathways:
- Pathway:WP4846
- Pathway:WP4860
- Pathway:WP4868
- Pathway:WP4927
- Pathway:WP4876
- Pathway:WP4883
- Pathway:WP4891
- Pathway:WP4884
- Pathway:WP4904
- Pathway:WP4936